These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 6365657)
1. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method. Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657 [TBL] [Abstract][Full Text] [Related]
2. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421). Krause HP; Keup U; Puls W Digestion; 1982; 23(4):232-8. PubMed ID: 6754513 [TBL] [Abstract][Full Text] [Related]
4. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Fölsch UR; Ebert R; Creutzfeldt W Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156 [TBL] [Abstract][Full Text] [Related]
5. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal. O'Dea K; Turton J Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743 [TBL] [Abstract][Full Text] [Related]
6. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Ranganath L; Norris F; Morgan L; Wright J; Marks V Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911 [TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-glucosidehydrolase inhibition and intestinal absorption of sucrose, water, and sodium in man. Caspary WF; Kalisch H Gut; 1979 Sep; 20(9):750-5. PubMed ID: 387540 [TBL] [Abstract][Full Text] [Related]
8. alpha-Glucosidase inhibition in obesity. William-Olsson T Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827 [TBL] [Abstract][Full Text] [Related]
9. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition. Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436 [TBL] [Abstract][Full Text] [Related]
10. Combined use of guar and acarbose in reduction of postprandial glycaemia. Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023 [TBL] [Abstract][Full Text] [Related]
11. Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man. Dimitriadis G; Tessari P; Go V; Gerich J Metabolism; 1982 Aug; 31(8):841-3. PubMed ID: 7047984 [TBL] [Abstract][Full Text] [Related]
12. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123 [TBL] [Abstract][Full Text] [Related]
13. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo. Madariaga H; Lee PC; Heitlinger LA; Lebenthal E Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164 [TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W Scand J Gastroenterol; 1995 Sep; 30(9):892-6. PubMed ID: 8578189 [TBL] [Abstract][Full Text] [Related]
15. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding. Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654 [TBL] [Abstract][Full Text] [Related]
16. Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose. Gerard J; Jandrain B; Pirnay F; Pallikarakis N; Krzentowski G; Lacroix M; Mosora F; Luyckx AS; Lefèbvre PJ Diabetes; 1986 Nov; 35(11):1294-301. PubMed ID: 3530858 [TBL] [Abstract][Full Text] [Related]
17. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus. Dimitriadis GD; Tessari P; Go VL; Gerich JE Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097 [TBL] [Abstract][Full Text] [Related]
18. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man. Uttenthal LO; Ukponmwan OO; Ghiglione M; Bloom SR Dig Dis Sci; 1987 Feb; 32(2):139-44. PubMed ID: 3542445 [TBL] [Abstract][Full Text] [Related]
19. Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose. Lembcke B; Fölsch UR; Caspary WF; Ebert R; Creutzfeldt W Digestion; 1982; 25(3):186-93. PubMed ID: 7160549 [TBL] [Abstract][Full Text] [Related]
20. Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor. Caspary WF Lancet; 1978 Jun; 1(8076):1231-3. PubMed ID: 77996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]